US 5,843,643 AGranted

Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid

OwnerPaul L. Ratnerinventor

Life of this patent

Estimating the term…

Loading patent…

Abstract

A method and composition are disclosed for transfecting eukaryotic cells using a DNA segment coupled to a site-specific chromosome-binding polypeptide. The polypeptide-DNA conjugate is referred to herein as a polypeptide-linked-rDNA (PLR) molecule. One example of a PLR molecule comprises a DNA segment containing a nucleotide sequence from a normally functioning human gene, coupled by means of a covalent crosslinking reagent to a site-specific chromosome-binding polypeptide (such as a transcription regulating polypeptide that binds to a specific nucleotide sequence in chromosomal DNA). After the PLR molecule enters the cytoplasm of a cell, such as by electroporation, the chromosome-binding polypeptide enables transport of the PLR molecule through the cytoplasm and into the nucleus, using a nuclear localization sequence (NLS) domain of the polypeptide. Inside the nucleus, the polypeptide scans the chromosomes until it binds to a specific chromosomal binding site. This positions the DNA segment of the PLR molecule near a target sequence (such as a defective gene) in the chromosome. The desired DNA segment contained in the PLR molecule has sufficient nucleotide sequence homology with the target gene to enable a recombination event to replace the target gene sequence with the desired gene sequence.

Claims13

Dependent claims

A composition of matter comprising a preparation of molecular conjugates in which each molecular conjugate comprises a polypeptide component which is chemically bonded to a DNA segment, wherein the preparation of molecular conjugates is useful for in vitro genetic transformation of eukaryotic cells in a population of eukaryotic cells having a targeted chromosomal region, in a manner which replaces the targeted chromosomal region with a different DNA sequence contained in the preparation of molecular conjugates, wherein:

A) each polypeptide component comprises:
(i) an amino acid sequence which functions as a nuclear localization sequence which enables migration of the molecular conjugate into a cell nucleus after the molecular conjugate has been inserted into a eukaryotic cell;
(ii) an amino acid sequence which functions as a chromosome-binding domain which binds in a site-specific manner to a chromosomal binding site on a chromosome which contains the targeted chromosomal region inside the cell nucleus;
and,
B) the DNA segment in each molecular conjugate has nucleotide sequence homology with the targeted chromosomal region on the chromosome comprising the chromosomal binding site, which enables homologous recombination between the targeted chromosomal region and the DNA segment;
and wherein the preparation of molecular conjugates is useful under in vitro conditions, to genetically transform eukaryotic cells having the targeted chromosomal region, by means of steps comprising the following:
(i) inserting the molecular conjugates into eukaryotic cells having the targeted chromosomal region, in an in vitro population of such cells;
(ii) culturing the eukaryotic cells in vitro for a sufficient period of time to allow:
(a) a nuclear localization sequence of a polypeptide component to transport a molecular conjugate into a cell nucleus;
(b) a chromosome-binding domain of a polypeptide component to bind in a site-specific manner to a chromosome-binding domain in a chromosome in the cell nucleus;
and,
(c) homologous recombination between a DNA segment of a molecular conjugate and a targeted chromosomal region;
and,
(d) replication of genetically transformed cells in which the targeted chromosomal region has been replaced by a DNA sequence contained in the DNA segment of the molecular conjugate;
and,
(iii) identifying and selecting genetically transformed cells, or cells descended therefrom, in which the targeted chromosomal region has been replaced by a DNA sequence carried by the molecular conjugates.

13 more elements

A composition of matter comprising a preparation of molecule conjugates in which each molecular conjugate, comprises a polypeptide component which is chemically bonded to a DNA segment, wherein the molecular conjugate enables in vitro genetic transformation of a population of targeted eukaryotic cells which have a chromosome inside a cell nucleus containing (a) a known chromosomal binding site which interacts in a site-specific manner with a known DNA-binding polypeptide having a known amino acid sequence, and (b) a targeted chromosomal DNA sequence which is intended to be replaced by a different DNA sequence carried by the DNA segment of the molecular conjugate,

wherein:
(a) the polypeptide component of the molecular conjugate comprises an amino acid sequence which functions as a nuclear localization sequence which enables migration of the molecular conjugate into the cell nucleus after the molecular conjugate has been inserted into a eukaryotic cell;
(b) the polypeptide component also comprises an amino acid sequence which binds in a site-specific manner to the known chromosomal binding site on the chromosome inside the cell nucleus;
(c) the DNA segment of the molecular conjugate comprises a first gene sequence which has nucleotide sequence homology with the targeted chromosomal DNA sequence, which enables homologous recombination between the targeted chromosomal DNA sequence and the DNA segment of the molecular conjugate;
(d) the DNA segment of the molecular conjugate also comprises a second gene sequence which serves as a marker gene in cells which contain DNA from the molecular conjugate, integrated into their chromosomes in a stable and inheritable manner, and which actively express the marker gene.

2 more elements

Dependencies are inferred from the claim text.

Facts

Application: 08/199,608Filed 22 Feb 1994 · continuation
Priority: 21 Feb 1992
Granted: 1 Dec 1998
Term ends: Not estimatedThe source records don’t support an estimate.

Classification5 codes

A61K 48/00
Medicinal preparations containing genetic material which is inserted into cells of the
A61K 47/645
Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is…:…
C12N 15/90
Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation: stable introduction of foreign DNA…
A61K
Medicines and medical preparations